Investor relations

The investor pages that follow are your resource for financial information about Aastrom Biosciences, Inc. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.

View all »   RSSRecent Press Releases

May 10, 2012
Aastrom Biosciences Reports First Quarter 2012 Financial Results

May 9, 2012
Aastrom Biosciences Announces First Patient Enrolled in REVIVE Phase 3 Clinical Trial of Ixmyelocel-T

View all »Events

May 10, 2012 at 4:30 PM ET
Aastrom Biosciences, Inc. First Quarter 2012 Earnings Call

May 10, 2012
SCAI Conference - DCM Phase 2a Data Presentation

Stock Information
NASDAQ: ASTM
Price:
2.25
Change:
- 0.07
Day High:
2.43
Day Low:
2.21
Volume:
298,900
4:00 PM ET on May 16, 2012
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools